Legacy Financial Advisors, Inc. Ironwood Pharmaceuticals Inc Transaction History

Legacy Financial Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 16, 2019	SELL	$7.8 - $16.13 $5,085 - $10,516	-652 Closed	0 $0
Q3 2018 Oct 30, 2018	BUY	$14.31 - $17.65 $758 - $935	53 Added 8.85%	652 $12,000
Q2 2018 Jul 17, 2018	BUY	$11.83 - $16.2 $780 - $1,069	66 Added 12.38%	599 $13,000
Q4 2017 Feb 09, 2018	BUY	$12.16 - $14.58 $6,481 - $7,771	533	533 $7,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.